NEFL and amyotrophic lateral sclerosis: Recent advances in immunoassay technology have made it possible to quantify NfL in blood with high analytic sensitivity, and using this new assay, blood NfL has been shown to distinguish patients with ALS from controls with high accuracy [20,21,22,23,24].